I Saldi Cambiamento Data
AbbVie USD 17.4B 410M 2026-09
Abbott USD 13.01B 423M 2026-09
Amgen USD 10.4B 300M 2026-09
AstraZeneca USD 16.21B 830M 2026-09
BioCryst Pharmaceuticals USD 218.25M 188.3M 2026-06
Bristol-Myers Squibb USD 13.07B 100M 2026-09
Eli Lilly USD 24.4B 1.43B 2026-09
Enanta Pharmaceuticals USD 16.96M 50.68M 2024-12
GlaxoSmithKline GBP 8.89B 480M 2026-09
Incyte USD 1.56B 110M 2026-09
J&J USD 25.4B 89M 2026-09
Karyopharm Therapeutics USD 35.07M 987K 2026-03
MacroGenics USD 32.83M 12.03M 2026-06
Merck USD 18.1B 1.5B 2026-09
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Novartis USD 14.52B 112M 2026-09
Novartis USD 15.03B 1.92B 2026-09
Pfizer USD 16.6B 1.57B 2026-09
Regeneron Pharmaceuticals USD 5.12B 830M 2026-09
Roche Holding CHF 30.36B 14.71B 2026-06
Sangamo BioSciences USD 356K 125K 2024-06
Takeda JPY 1.19T 32.9B 2026-09
Tectonic Therapeutic USD 0 0 2024-12
TG Therapeutics USD 259.94M 19.6M 2026-09
Ultragenyx Pharmaceutical USD 173M 41M 2026-09
Xencor USD 116.52M 65.3M 2026-09